4//SEC Filing
GOLDSTEIN JOSEPH L 4
Accession 0001968202-24-000023
CIK 0000872589other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:07 PM ET
Size
7.1 KB
Accession
0001968202-24-000023
Insider Transaction Report
Form 4
GOLDSTEIN JOSEPH L
Director
Transactions
- Award
Common Stock
2024-01-02+135→ 6,382 total - Award
Non-Qualified Stock Option (right to buy)
2024-01-02+1,607→ 1,607 totalExercise: $888.34Exp: 2034-01-02→ Common Stock (1,607 underlying)
Footnotes (2)
- [F1]Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.
- [F2]On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001225474
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:07 PM ET
- Size
- 7.1 KB